Echo Therapeutics, Inc. (NASDAQ: ECTE) is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Symphony® CGM System as a non-invasive, wireless, continuous glucose monitoring system for use initially in the critical care setting, as well as in patients with diabetes in the outpatient setting. Echo is also developing it needle free skin preparation component of Symphony, the Prelude® SkinPrep System, as a platform technology to allow for enhanced delivery of topical pharmaceuticals.